A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies
The objective of the present study was to evaluate the contribution of the shared epitope (SE), the rheumatoid arthritis (RA) protection model, and the occurrence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in RA patients from a genetically diverse population. One hundred and forty Br...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Associação Brasileira de Divulgação Científica
2008-06-01
|
Series: | Brazilian Journal of Medical and Biological Research |
Subjects: | |
Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000600010 |
_version_ | 1818849313585889280 |
---|---|
author | P. Louzada-Júnior M.V.C. Freitas R.D.R. Oliveira N.H.S. Deghaide R.A. Conde M.B. Bertolo E.A. Donadi |
author_facet | P. Louzada-Júnior M.V.C. Freitas R.D.R. Oliveira N.H.S. Deghaide R.A. Conde M.B. Bertolo E.A. Donadi |
author_sort | P. Louzada-Júnior |
collection | DOAJ |
description | The objective of the present study was to evaluate the contribution of the shared epitope (SE), the rheumatoid arthritis (RA) protection model, and the occurrence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in RA patients from a genetically diverse population. One hundred and forty Brazilian RA patients and 161 matched controls were typed for HLA-DRB1 alleles using amplified DNA hybridized with sequence-specific oligonucleotide probes or primers. Patients were stratified according to the presence or absence of SE (DRB1*0401, *0404, *0405, *0101, *1001, and *1402), of the DERAA alleles (DRB1*0103, *0402, *1102, *1103, *1301, *1302, and *1304), and X (all other alleles). Anti-CCP antibodies were measured by ELISA. The combined frequency of SE-positive alleles was significantly greater (76.4 vs 23.6%, P < 0.0001) than the controls. The SE/SE and SE/X genotypes were over-represented (P < 0.0001, OR = 6.02) and DERAA/X was under-represented in RA patients (P < 0.001, OR = 0.49), whereas the frequencies of the SE/DERAA, X/X and X/DERAA genotypes were not significantly different from controls. The frequency of anti-CCP antibodies was higher in SE-positive patients than in SE-negative patients (64.6 vs 44.7%, P = 0.03; OR = 2.25). Although the Brazilian population is highly miscegenated, the results of this study support the findings observed in most genetically homogeneous populations with RA; however, they are not mutually exclusive but rather complementary. The participation of DRB1-DERAA alleles in protection against RA was also observed (OR = 0.4; 95%CI = 0.23-0.68). |
first_indexed | 2024-12-19T06:31:15Z |
format | Article |
id | doaj.art-e3c16dc0e0274ff3ae95ea4cdfd94962 |
institution | Directory Open Access Journal |
issn | 0100-879X 1414-431X |
language | English |
last_indexed | 2024-12-19T06:31:15Z |
publishDate | 2008-06-01 |
publisher | Associação Brasileira de Divulgação Científica |
record_format | Article |
series | Brazilian Journal of Medical and Biological Research |
spelling | doaj.art-e3c16dc0e0274ff3ae95ea4cdfd949622022-12-21T20:32:23ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research0100-879X1414-431X2008-06-01416493499A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodiesP. Louzada-JúniorM.V.C. FreitasR.D.R. OliveiraN.H.S. DeghaideR.A. CondeM.B. BertoloE.A. DonadiThe objective of the present study was to evaluate the contribution of the shared epitope (SE), the rheumatoid arthritis (RA) protection model, and the occurrence of anti-cyclic citrullinated peptide (anti-CCP) antibodies in RA patients from a genetically diverse population. One hundred and forty Brazilian RA patients and 161 matched controls were typed for HLA-DRB1 alleles using amplified DNA hybridized with sequence-specific oligonucleotide probes or primers. Patients were stratified according to the presence or absence of SE (DRB1*0401, *0404, *0405, *0101, *1001, and *1402), of the DERAA alleles (DRB1*0103, *0402, *1102, *1103, *1301, *1302, and *1304), and X (all other alleles). Anti-CCP antibodies were measured by ELISA. The combined frequency of SE-positive alleles was significantly greater (76.4 vs 23.6%, P < 0.0001) than the controls. The SE/SE and SE/X genotypes were over-represented (P < 0.0001, OR = 6.02) and DERAA/X was under-represented in RA patients (P < 0.001, OR = 0.49), whereas the frequencies of the SE/DERAA, X/X and X/DERAA genotypes were not significantly different from controls. The frequency of anti-CCP antibodies was higher in SE-positive patients than in SE-negative patients (64.6 vs 44.7%, P = 0.03; OR = 2.25). Although the Brazilian population is highly miscegenated, the results of this study support the findings observed in most genetically homogeneous populations with RA; however, they are not mutually exclusive but rather complementary. The participation of DRB1-DERAA alleles in protection against RA was also observed (OR = 0.4; 95%CI = 0.23-0.68).http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000600010Susceptibility to rheumatoid arthritisHLABraziliansShared epitopeAnti-cyclic citrullinated peptide |
spellingShingle | P. Louzada-Júnior M.V.C. Freitas R.D.R. Oliveira N.H.S. Deghaide R.A. Conde M.B. Bertolo E.A. Donadi A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies Brazilian Journal of Medical and Biological Research Susceptibility to rheumatoid arthritis HLA Brazilians Shared epitope Anti-cyclic citrullinated peptide |
title | A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies |
title_full | A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies |
title_fullStr | A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies |
title_full_unstemmed | A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies |
title_short | A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrunillated peptide antibodies |
title_sort | majority of brazilian patients with rheumatoid arthritis hla drb1 alleles carry both the hla drb1 shared epitope and anti citrunillated peptide antibodies |
topic | Susceptibility to rheumatoid arthritis HLA Brazilians Shared epitope Anti-cyclic citrullinated peptide |
url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2008000600010 |
work_keys_str_mv | AT plouzadajunior amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT mvcfreitas amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT rdroliveira amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT nhsdeghaide amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT raconde amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT mbbertolo amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT eadonadi amajorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT plouzadajunior majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT mvcfreitas majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT rdroliveira majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT nhsdeghaide majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT raconde majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT mbbertolo majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies AT eadonadi majorityofbrazilianpatientswithrheumatoidarthritishladrb1allelescarryboththehladrb1sharedepitopeandanticitrunillatedpeptideantibodies |